Jump to content
Main menu
Main menu
move to sidebar
hide
Navigation
Main page
Recent changes
Random page
Help about MediaWiki
Special pages
Surgopaedia
Search
Search
Appearance
Create account
Log in
Personal tools
Create account
Log in
Pages for logged out editors
learn more
Contributions
Talk
Editing
Hyperthyroidism
Page
Discussion
English
Read
Edit
Edit source
View history
Tools
Tools
move to sidebar
hide
Actions
Read
Edit
Edit source
View history
General
What links here
Related changes
Page information
Appearance
move to sidebar
hide
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
The clinical state of elevated thyroid hormone action in tissues, usually due to inappropriately high constitutive secretion of thyroid hormone from the thyroid == '''Epidemiology''' == * Prevalence 1.2% in USA == '''Aetiology''' (most commonly those in bold) == * '''Associated with normal or high RAI uptake''' (indicates de novo synthesis of hormone, so can be treated with a thionamide (i.e. carbimazole)) ** '''Graves disease''' ** '''TMNG''' ** '''Toxic adenoma''' ** Trophoblastic disease ** TSH-producing pituitary adenoma ** Thyroid hormone resistance * '''Associated with no or minimal RAI uptake''' (indicates either inflammation and destruction of thyroid tissue with release of pre-formed hormone into the circulation, or an extra-thyroidal source of thyroid hormone; so thionamides won't help in these disorders) ** Thyroiditis *** Painless thyroiditis (silent or lymphocytic) *** Amiodarone-induced thyroiditis *** Subacute granulomatous thyroiditis *** Acute thyroiditis *** Palpation thyroiditis ** Iatrogenic thyrotoxicosis - excessive, intentional replacement, or factitious ** Struma ovarii ** Follicular thyroid cancer metastases (ectopic) == '''Pathophysiology''' == * Divided into two groups ** Overt - supressed TSH, elevated T3/T4 ** Subclinical - supressed TSH, normal T3/T4. Likely to be milder in presentation. == '''Presentation''' == * Tremor * Heat intolerance * Tachycardia/AF * Increased GIT motility * Muscle weakness * Anxiety * Embolic events * Rarely, severe cardiovascular complications ** Cardiomyopathy ** CCF ** Cardiovascular collapse ** Death * Thyroid storm ** Rare life-threatening complication of hyperthyroidism - severe clinical manifestations ** Can be precipitated by an acute event (cessation medications, infection, trauma, acute iodine load) ** Tachycardia >140, febrile, agitation, delirium, progressing to psychosis, stupor, coma ** Altered mentation is the main differentiating factor from 'normal' hyperthyroidism ** Treat with ICU, beta blockers, medical treatment of cause of hyperthyroidism, glucocorticoids to reduce T4-T3 conversion, and treat the cause of the storm ** The main indication for surgery is patients who had a severe reaction to medical management of hyperthyroidism, had to stop that agent, then get a thyroid storm, with no other treatment options available. Otherwise, it is really an endocrinology emergency. == '''Graves disease''' == * Epidemiology ** Most common cause of hyperthyroidism * Risk factors ** Female (8:1) ** Typically presents between 20-40yo ** Post-partum is a vulnerable period * Pathophysiology ** Autoimmune systemic disorder ** Caused by thyrotropin receptor antibody (TRAb) binding to and stimulating the TSH receptor, resulting in excessive synthesis and secretion of thyroid hormone ** Associated with Hashimoto thyroiditis, SLE, RA, pernicious anaemia and Addison disease * Presentation ** Gland feels diffusely and symmetrically enlarged and firm ** Graves orbitopathy (25-30% of patients) *** Associated with smoking, high levels of antibodies. RAI can worsen eye disease. *** Pathophysiology **** TSHRs (TSH receptors) are also found on orbital fibroblasts and adipocytes. **** These can be activated by TRAb, which causes local inflammation, fibroblast proliferation, adipogenesis, and mucopolysaccharide deposition **** This creates an overall higher volume of extra-orbital connective tissue and orbital connective tissue, leading to pressure within the orbit and displacement of the eyeball forward **** That causes extra-ocular muscle dysfunction and impaired venous drainage, and worsens the swelling *** Presentation **** Ocular myopathy - diplopia, exophthalmos - due to the muscle fibrosis **** Congestive ophthalmopathy - watery gritty eyes, periorbital oedema, conjunctival injection/chemosis **** Can cause vision loss from corneal lesions or optic nerve compression **** Loss of colour vision is an ophthalmologic emergency *** Mild eye disease may resolve spontaneously, but mod-severe disease won't (only about 30% improve) *** Should '''treat hyperthyroidism with thionamides (carbimazole/PTU) or surgery''', not RAI (can cause worsening) **** RAI is ok in mild eye disease *** '''Treat eyes with glucocorticoids''', or if proptosis/soft tissue involvement/diplopia are present, treat with teprotumumab if available (extremely expensive and not available yet in Australia as far as I know) *** Total thyroidectomy is a good option *** Local measures - artificial tears, raising head of bed at night (theoretically reduces orbital congestion), need to stop smoking ** Skin manifestations - pretibial myxoedema and acropachy * Workup ** TSH and free T4/T3 ** TRAb (diagnostic) ** Technetium-99-pertechnetate scintigraphy can differentiate from toxic nodular disease based on uptake pattern * Treatment - three options ** Antithyroid drugs *** '''Methimazole (carbimazole) daily''' **** Start on carbimazole 5mg daily and titrate upwards **** Direct inhibition of TPO effect **** Rapid clinical onset, but TSH rise may take weeks **** Decreases thyroid hormone synthesis and control hyperthyroidism in 90% of patients within several weeks **** Intent is to induce remission **** Relapse occurs after stopping the drug in most patients **** Side effects - bone marrow suppression - agranulocytosis/neutropaenia **** Commonly used for pre-op preparation, or for temporary management of pregnant patients with Graves' disease **** '''Propylthiouracil (PTU)''' is an alternative, mostly only used during first trimester and in thyrotoxic crisis now ***** Start at 50mg TDS in most cases ***** Inhibits TPO but also blocks conversion of T4 to T3 in target tissues ***** Risks agranulocytosis and fulminant liver failure **** Long-term treatment with either is safe *** '''Radioactive iodine (131-I)''' **** Works in >90% with a single dose **** Treatment of choice for most patients **** RAI is taken up into cells by sodium iodide symporter - first step in thyroid hormone synthesis - and then causes cell death via emission of short-path length beta particles **** Commonly become hypothyroid and have to take replacement afterwards **** Side effects - neck pain from radiation thyroiditis (mild), sialadenitis, xerostomia, temporary worsening of thyrotoxicosis, and sometimes worsening of Graves' ophthalmopathy, which may be ameliorated with glucocorticoids **** Small increased risk of secondary malignancy - at 30 years, the risk was 12.5% vs 10.2% in controls. Doses <100mCu are low-risk. **** Contraindicated during pregnancy or lactating mothers, and used in relatively few adolescents/children ** '''Surgery''' *** Bilateral near-total or total thyroidectomy is virtually 100% effective *** Will need levothyroxine *** Resolves any questions of nodules/cancer *** Safe in many pregnant women/breastfeeding *** Pre-op preparation required **** Goals: aim T3 ideally <15 or at least <20. TSH does not need to be normal, and it takes an extra few weeks to become normal. **** Antithyroid drugs (methimazole) given for 3-6 weeks beforehand **** Beta blockers can help control thyrotoxicosis/tachycardia if it still present. **** Lugol's solution was used in the past for this - 5-7 drops TDS up to 10 days before surgery - reduces thyroid hormone secretion and decreases vascularity of the gland and surgical blood loss. Risk of hyperthyroidism via Jod-Basetow effect if continued longer than this. **** Glucocorticoids can be given for refractory cases **** Risk of thyroid storm - see above **** Test for hypocalcaemia and give calcium/vitamin D if low **** Consider ICU post-op * Note situations where surgery is the best options: ** Patient factors *** Need or desire for rapid reversal *** Pregnancy or post-partum or wants to become pregnant ** Disease factors *** Active Graves ophthalmopathy *** Periodic paralysis *** Failure or contraindications to other options - fluctuating TSH or ongoing high dose requirement ** Other indications for surgery *** Known or suspected thyroid malignancy *** One or more large thyroid nodules *** Co-existing primary hyperparathyroidism requiring surgery *** Large goitres with compressive symptoms == '''Toxic single adenoma''' == * Single benign monoclonal thyroid tumours that autonomously oversecrete thyroid hormone, existing within an otherwise normal or non-toxic nodular thyroid gland * Risk factors ** Mild female predominance ** Median age 50-60yo * Pathophysiology ** Constitutively active mutations in the TSH receptor gene ** Usually >3cm ** Evolves through a course of subclinical to clinical hyperthyroidism ** Virtually never malignant * Workup ** As per Toxic MNG * Treatment ** Antithyroid drugs - seldom if ever chosen, as recurrence is guaranteed, and remission does not occur ** Radioactive iodine - effective, and euthyroidism is re-established in 80% with a single dose. Not ok in pregnancy/lactation. Can have recurrence. ** Surgery - virtually 100% effective *** Can be unilateral thyroidectomy, unless bilateral suspicious nodules and/or symptomatic goitre ** Percutaneous ablative techniques *** Either ethanol or RFA *** Requires much further study before being accepted - not very well understood currently with decent complication rate == '''Toxic MNG (Plummer's Disease)''' == * An enlarged nodular thyroid containing one or more autonomously functioning nodules leading to a state of hyperthyroidism ** Second most common cause of hyperthyroidism * Risk factors ** Older age - uncommon <50yo ** Iodine deficient region ** Female (5:1) * Pathophysiology ** Autonomously functioning nodules occur after a mutation in TSH receptor gene leads to constitutive synthesis and secretion of thyroid hormones ** Rarely malignant, do not generally require biopsy * Presentation ** Develops slowly from subclinical hyperthyroidism into thyrotoxicosis * Workup ** TFTs and thyroid Abs ** Exclude Graves and autoimmune thyroiditis ** Nuclear scintigraphy - first-line imaging *** Identifies location and distribution of autonomously functioning nodules and/or regions ** USS *** Also useful to characterise any nodules that may require biopsy * Management - three options ** Antithyroid drugs - virtually never used for definitive treatment, but can help as pre-op preparation *** Use methimazole before both RAI and surgery, with or without beta blockade *** Start on carbimazole 5mg daily ** Radioactive iodine - effective, but generally takes about 6 months to work. Especially good in settings of high operative risk. Second dose necessary in about 25%. *** Most common option in USA *** Need higher dose than in Graves disease because of lower uptake ** Surgery - prompt, permanent cessation of hyperthyroidism (within a month). Removal of Goitre. Treatment of any nodules/malignancy. Will need thyroxine. Can be more difficult operation than normal thyroidectomy due to size of goitre. Need near-total or total thyroidectomy. == '''Amiodarone-induced thyrotoxicosis''' == * See [[thyroiditis]]
Summary:
Please note that all contributions to Surgopaedia may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
Surgopaedia:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Search
Search
Editing
Hyperthyroidism
Add topic